All posts by imreal

Complimentary Webinar to Showcase Emerging Field of Cone Beam CT Imaging


“Cone Beam CT imaging techniques significantly reduce the complexity by removing the need for ‘slip ring’ technology that is essential for traditional CT systems.” observes Dr. Yorkston.

RadSite™, a CMS-recognized accrediting agency promoting quality-based advanced diagnostic imaging, is offering a complimentary webinar called An Overview of Cone Beam CT Imaging. The session will take place on May 6, 2020, at 2:00 p.m. ET and will last approximately one hour. Click here to register.

Leading experts in quality imaging will discuss the latest in Cone Beam CT Imaging in the United States in the May 6th webinar. Thousands of systems are now being used for diagnostic and interventional imaging. The session will highlight the opportunities and challenges associated with Cone Beam CT systems, including the need for national quality and performance standards.

The session will be moderated by Eliot Siegel, M.D., RadSite Chair, Standards Committee, and will feature the following speakers:

-David Luick, Vice President, Tungsten Medical Network

-Jenna Roller, PA-C, Clinical Applications Specialist, CurveBeam

-John Yorkston, Ph.D., Senior Research Scientist, Carestream Health Inc.

“It is interesting to compare the technology between a traditional CT system, where the patient must be moved through the fan beam of x-rays as it rotates around the patient multiple times, to a Cone Beam CT system, which uses a large-area detector to image an extended volume of the patient in a single rotation,” observes Dr. Yorkston. “Cone Beam CT imaging techniques significantly reduce the complexity by removing the need for ‘slip ring’ technology that is essential for traditional CT systems.”

“Cone Beam CT imaging has become a centerpiece for otolaryngology specialty care,” notes David Luick. “By allowing medical professionals to conveniently image fields of study covering the ears, nose, and throat, the provider can conveniently access a high resolution image at a lower dose that conventional CT exams. Cone Beam CT images can be used for both diagnosis and in the aid of treatment. A good example is image-guided sinus surgery.”

“Cone Beam CT systems are designed to capture three-dimensional weight-bearing and non-weight-bearing volumetric images of the body extremities,” adds Jenna Roller. “I will share with the webinar attendees some of the opportunities associated with Cone Beam CT systems, such as how it can support orthopedic practices and other specialty areas, along with some of the latest advancements.”

All three speakers serve on RadSite’s Cone Beam CT Standards Committee, which has been meeting for two years. RadSite anticipates the release of its new Cone Beam CT MIPPA Accreditation Program this summer, which features specialty standards for both dental and medical imaging providers.

RadSite is hosting two webinars related to Cone Beam CT imaging, each lasting one hour:

-An Overview of Cone Beam CT Imaging is scheduled on May 6, 2020, at 2:00 p.m. ET. Click here to register.

-2020 RadSite Cone Beam CT Standards Overview is scheduled on June 17, 2020, at 2:00 p.m. ET. Click here to register.

To listen to RadSite’s last webinar, “2020 RadSite Standards and Accreditation Updates,” which took place on April 15, 2020, or to listen to other webinars that have been previously recorded, go to https://radsitequality.com/webinars/.

RadSite offers a comprehensive, affordable, quality-based accreditation program that evaluates providers on established industry standards and best practices. Working with health plans and their participating providers helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services and more than 350 payers and radiology benefit managers.

                                                                 ###

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Murrieta Genomics and SimplSeq to Participate in Life Science Nation’s Digital RESI Partnering Event April 29 and 30


We are now ready to share this with investors, and this is the perfect platform to launch our fundraising.

Murrieta Genomics, the launch pad for genomic sequencing startups, and SimplSeq, a wholly owned subsidiary company focused on innovative sample preparation for genomic sequencing, will be participating in a virtual partnering event being held April 29 and 30. The event is hosted by Life Science Nation, an organization founded to help move science forward and be part of the change that is coming to the life science domain.

“Murrieta Genomics wants to launch the next great genomic sequencing companies,” stated Jay Goth, CEO of Murrieta Genomics. “We believe that we are in the very early phase of precision medicine and genomic sequencing is one of the fundamental technologies driving this new trend. Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services and capital.”

The digital partnering event is an innovative approach to connecting companies that was developed in response to the current Coronavirus pandemic. Life Science Nation had to shift their European conference held in March to a digital platform due to the restrictions on travel and found that opening the conference to a virtual audience was a game changer.

“Digital RESI Global doubled our predicted attendee turnout with investment partners and fundraising CEOs. The metrics are actually quite interesting and surprised us in revealing the pent-up demand for action in the life science arena in these troubled times,” stated Dennis Ford, founder and CEO of Life Science Nation. “Partnering led the way and Panels, Workshops and Company Presentations did remarkably well. I never would have thought that these troubled times would have contributed to a new model that seems to be shifting the paradigm.”

During the March RESI conference, over 1,200 meetings were booked over three major continents, with 546 attendees successfully scheduling meetings. This bodes well for the upcoming partnering conference, according to Goth. “I attended the RESI conference in January in San Francisco and was impressed by the number of meetings I had with investors and the quality of those meetings,” he said. “You can reach out to qualified investors and request a meeting and if they agree, then there is a pre-existing interest in what you have to say.”

“SimplSeq is a new internally developed incubator company,” said John Powers, COO of Murrieta Genomics and CEO of SimplSeq. “Brandon Young, our CTO and Lab Director, has been at the bench for over 20 years and he has encountered frustrations with traditional sample preparation methods and decided to come up with some new ideas. As he developed these concepts, we realized that he was transforming a critical part of the genomic sequencing process and we decided to patent and commercialize them. We are now ready to share this with investors, and this is the perfect platform to launch our fundraising.”

Murrieta Genomics is also on the lookout for new potential candidates for the incubator. “We can offer genomic startups critical resources that most life science incubators and accelerators don’t,” said Goth. “For example, our advisory board is comprised of industry leaders – not only in the genomic and science areas, but also in necessary fields including legal, accounting, human resources and investment banking.”

“We don’t think that genomic startups should be spending money building a lab, hiring technicians, and burning up capital to generate the data they need to prove out their concept. We offer them the sequencing know-how and access to resources that would normally be cost prohibitive with no bench fees or overhead costs except for hard costs such as reagents. People with genomic domain knowledge can prove their science while building a business model before reaching out to investors.”

Both companies will also be participating in the next digital RESI conference slated for early June. At this event there will be one on one partnering, investor panels, workshops for life science entrepreneurs, virtual pitch sessions, innovation challenges and more. It is scheduled for three days, June 8, 9 and 10. You can register for Digital RESI 3-Day Conference June 8-10 here and use the promo code “RESIMG100” to save $100 off your registration.

LSN invites all global early-stage companies across Biotech, Medtech, Diagnostics & Digital Health to apply for the Digital RESI June 8-10 Innovation Challenge. The top 30 scoring companies will virtually showcase their technology on their own dedicated page featured on the Digital RESI “Live Agenda,” gaining more exposure in LSN’s Global Fundraising Ecosystem of investors and strategic partners. You can apply for the Innovation Challenge here. The application deadline is May 11th.

About Murrieta Genomics

Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. The company provides Next Generation Sequencing (NGS) services, hands-on consulting, review, appraisal and guidance. In addition, it provides help with company value propositions and potential seed funding support to qualified incubator graduates. For more information visit http://www.murrietagenomics.com.

Murrieta Genomics is part of the Murrieta Innovation Center, a building owned by the city of Murrieta and dedicated to supporting life science companies. The Innovation Center has medical device, therapeutic, software, clinical research and of course genomic companies that are working hard to advance new ideas and innovations that can impact the world in a positive way. The Center is also a resource for all types of local startup companies, offering services and workshops from a local SBDC, several veteran organizations, a SCORE branch and more.

About Life Science Nation’s RESI Conference

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What is unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics, and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

Specialty telehealth vendor Anytime Pediatrics achieves record growth in Q1


News Image

We are humbled and proud to be a company ready to respond in this time of need.

Anytime Pediatrics, the first and only pediatric-specific telemedicine solution, announced explosive growth today, making it one of the fastest growing healthcare technology companies and a true innovator in virtual care. Anytime Pediatrics is helping patients stay connected with pediatricians they know and trust during the COVID-19 pandemic.

“I have always believed in the power of relationships, especially between physicians, clinicians and their patients,” said Mick Connors, MD and CEO of Anytime Pediatrics. “Our rapid growth is a testament to the fact that relationships still matter, especially for the unique bond between a family and their child’s pediatrician. This crisis has ‘pushed’ pediatricians and patients to virtual care, not due to the love of technology, but because we look for unique ways to foster the relationships we truly need in our lives. We are humbled and proud to be a company ready to respond in this time of need.”

The company’s early 2020 success validates that “pediatric-specific” really matters, and pediatricians value a complete telemedicine product, community and innovation. Anytime Pediatrics believes in keeping care local, and is committed to delivering technology that strengthens relationships and supports healthy lives.

“I’m glad that this horrible crisis has forced me to embrace a new way of practicing medicine, and I’m grateful that I found a partner in this endeavor that was as quick, helpful, easy to work with and responsive as you guys,” said Dr. John Dallenbach, owner of East Elm Pediatrics. “We all love Anytime Pediatrics.”

About Anytime Pediatrics

Anytime Pediatrics is an industry leading telemedicine solution, built exclusively for pediatricians and their patients. The innovative technology company is advancing how quality care can be delivered within the medical home and is committed to making healthcare more convenient, accessible and affordable. The fast growing start up, Anytime Telehealth Inc, was founded in 2016 and is currently headquartered in Nashville, TN.

Share article on social media or email:

NeoTract Designates Dr. Peter Burrows as UroLift® Center of Excellence


News Image

“Dr. Peter Burrows has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Peter Burrows, M.D., Arizona Center for Vasectomy and Urology, P.C. in Tucson, AZ, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Burrows has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Peter Burrows has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

PunchOut2Go Appoints New VP of Technology and Financial Controller


News Image

Jamie’s experience and expertise will support our expansion with technology and processes that ensure we remain the fastest, most reliable, and secure platform for seamless B2B integration.

PunchOut2Go, a leading Integration Platform as a Service (iPaaS) provider for B2B eCommerce and eProcurement, today announced the appointment of Jamie Cairns as Vice President of Technology and Ashley Fitch as Financial Controller.

Jamie Cairns joins PunchOut2Go as Vice President of Technology with almost 30 years of leadership experience in platform delivery, cloud architecture, and information security. Cairns will drive PunchOut2Go’s technology strategy—implementing tools, technologies, and processes to support PunchOut2Go’s global B2B integration and automation platform. Before he was appointed VP of Technology at PunchOut2Go, Cairns served in numerous technology leadership roles, including as Chief Information Officer of WorldStrides and Vice President of Infrastructure Services for S&P Global, where he managed infrastructure and critical services that supported the S&P 500.

“We’re delighted Jamie Cairns has joined us to take a key leadership role in PunchOut2Go’s technology strategy and security posture. PunchOut2Go is growing rapidly as B2B buyers and suppliers embrace the benefits of buy-side and sell-side platform integration for PunchOut catalogs, purchase order automation, eInvoicing, and more. Jamie’s experience and expertise will support our expansion with technology and processes that ensure we remain the fastest, most reliable, and secure platform for seamless B2B integration,” said PunchOut2Go CEO Brady Behrman.

As PunchOut2Go’s new Financial Controller, Ashley Fitch will oversee the company’s accounting team as it supports PunchOut2Go’s global expansion. Fitch comes to PunchOut2Go with over 20 years of experience as an accountant and financial analyst. Her previous roles include Senior Accountant at the CFA (Chartered Financial Analyst) Institute. She has also served as a financial analyst and accountant for organizations that include the University of Virginia Alumni Association and Partners Financial Federal Credit Union.

“PunchOut2Go supports tens of thousands of business-to-business transactional integrations for organizations in over 40 countries. Ashley will oversee all of PunchOut2Go’s accounting staff and activities. Her unmatched experience as an accountant and analyst for international organizations will play a vital role as our company scales its global operations,” said Behrman.

The PunchOut2Go iPaaS connects any eCommerce application to any eProcurement, spend management, or enterprise resource planning platform, enabling features such as PunchOut Catalogs, B2B purchase order automation, eInvoicing, and electronic quotes. PunchOut2Go streamlines B2B procurement by automating data exchange, reducing errors, and increasing procurement to commerce transparency.

About PunchOut2Go:

PunchOut2Go is a global B2B integration company specializing in connecting commerce business platforms with eProcurement spend management and enterprise resource planning applications, allowing companies around the world to streamline purchasing processes and transact electronically. Harnessing the power of the cloud, PunchOut2Go’s flexible iPaaS technology seamlessly links business applications to automate the flow of purchasing data and reduces integration complexities for PunchOut catalogs, electronic purchase orders, eInvoices and other B2B sales order automation documents in order to accelerate business results. Learn more at https://www.punchout2go.com.

Share article on social media or email:

Efforts to Promote Physical Activity and Engagement With Children Discussed On “In Depth” With Laurence Fishburne


News Image

Most kids and teens spend up to seven hours a day watching TV or engaging with a computer or phone.

The former star of “CSI: Crime Scene Investigation,” Laurence Fishburne, is the host of the educational show “In Depth”. The TV program discusses a wide array of topics that uniquely affect people of all demographics. An upcoming episode will feature industry professionals who will explore ways to encourage physical activity and engagement with children.

About 12.5 million youths are obese. Obesity in kids is on the rise, and the lack of consistent physical activity is not helping. Medical and nutrition experts recommend that children and adolescents engage in 60 minutes of physical activity daily. However, only 1 in 3 three children are physically active every day.

To promote physical activity and engagement in children, health professionals recommend finding physical activities that are equally age-appropriate and engaging for them, such as playing soccer, riding a bicycle, or swimming. Another recommended tip is to turn off the television and computer. Most kids and teens spend up to seven hours a day watching TV or engaging with a computer or phone. Limit overall daily screen time to 1-2 hours a day and use that free time for physical engagement and activities.

Since overweight adolescents have a 70% higher chance of becoming overweight or obese as an adult, it is imperative to encourage healthy exercise habits while they are young. “In Depth” will provide more details about how to promote physical engagement and activity with youths in the new episode airing soon. It will also discuss how the recent coronavirus pandemic has led to a steep increase in screen time for children.

“In Depth” with Laurence Fishburne is a cautiously examined television program before broadcast. The educational show has received numerous accolades.

Share article on social media or email:

Casper Medical Imaging, Radiologic Medical Services, and Naugatuck Valley Radiological Associates Transition from Affiliate to Strategic Radiology Shareholder Members


Chair and CEO, Strategic Radiology

By incorporating our affiliate members as owners, we are building a more diverse, innovative, and collaborative team to bring top-notch care to our respective patients and our communities.

Three Strategic Radiology (SR) affiliate practices—Casper Medical Imaging (CMI), Casper, Wyo., Radiologic Medical Services (RMS), Coralville, Iowa, and Naugatuck Valley Radiological Associates (NVRA), Waterbury, Conn.—have transitioned to owner status as the coalition moves toward one class of membership—ownership.

Strategic Radiology launched the affiliate program in 2014 to enable smaller practices to enjoy the benefits of membership. When the then eight-radiologist Casper Medical Imaging became SR’s first affiliate practice, the coalition was composed primarily of large private practices. Today, 17 of SR’s 27 member groups are affiliate practices, a diverse group ranging from practices of 8 to more than 60 radiologists.

“We recognize that a practice’s value is not measured in its number of radiologists, but in the strength of its radiologist and employee commitment to high-quality, independent medicine,” said Arl Van Moore Jr, MD, FACR, CEO and chair, Strategic Radiology. “By incorporating our affiliate members as owners, we are building a more diverse, innovative, and collaborative team to bring top-notch care to our respective patients and our communities.”

Casper Medical Imaging is an independent physician practice with nine radiologists founded in 1971, the largest full-service independent radiology group in Wyoming, and the first affiliate to convert to ownership status with Strategic Radiology. In partnership with Wyoming Medical Center, CMI also manages a joint venture outpatient imaging center, Outpatient Radiology, which provides a wide range of imaging services, including full-service women’s imaging, comprehensive vein services, and a unique micro-invasive MSK clinic with a clientele that includes elite athletes from all over the globe.

“Becoming a Strategic Radiology owner continues Casper Medical Imaging’s commitment to remain independent and recruit and retain the best radiologists, while pursuing exceptional patient quality and care,” said Seth Iverson, MD, President, CMI.

Radiologic Medical Services, an eight-radiologist practice founded in 1971, is the second affiliate practice to convert to ownership. It provides full-service radiology to its hospital partner and maintains a strong local presence through active community involvement and two full-service outpatient imaging centers that provide high-quality, timely diagnostic imaging interpretations and therapeutic image-guided interventions.

““Strategic Radiology embodies the teamwork, collaboration, continuous improvement, and positive energy that are so important when it comes to caring for our patients,” said Colin O’Brien, MD, president, RMS. “The RMS team looks forward to our continued participation as we transition to full membership responsibilities.”

Naugatuck Valley Radiological Associates, a 13-radiologist practice that serves two hospitals, joined SR in 2018 and is the third affiliate to become an owner. The practice employs 90 people at four outpatient imaging centers and a business-services organization; it received the American College of Radiology’s first Diagnostic Imaging Center of Excellence designation in Connecticut.

“The SR vision, services, and platform for collaboration with a national group of practice leaders were key opportunities that we believed added value to our organization when we chose to become affiliate members,” said Geoffrey Manton, MD, President, NVRA. “As our organizations have grown and evolved, it became a natural fit for us to move to core membership. We are proud to be members of SR and look forward to continued support and services that have been beneficial in numerous aspects of our business and medical practice.”

Affiliate practices that transition to ownership will become shareholders and voting members of Strategic Radiology. The coalition is governed by a Board of Managers that meets quarterly, on which all shareholder practices are represented. A smaller Executive Committee meets bi-weekly and brings new, strategic business to the Board for vote.

About Strategic Radiology    

Strategic Radiology is a coalition of independent, private radiology practices, representing more than 1,100 radiologists. The coalition’s goal is to achieve higher quality patient care and more cost-efficient delivery of medical imaging through an integrated approach of shared data and best practices, interchanging clinical expertise, and consolidating certain practice expenses. It operates the nation’s first radiology-focused Patient Safety Organization listed by the Agency for Healthcare Research and Quality. http://www.StrategicRadiology.org.

SR Members:

  • Asheville Radiology Associates; Asheville, NC
  • Casper Medical Imaging and Outpatient Radiology; Casper, WY
  • Central Illinois Radiological Associates; Peoria, IL
  • Chesapeake Medical Imaging; Annapolis, MD
  • Diagnostic Imaging Northwest; Portland, OR
  • Gaston Radiology; Gastonia, NC
  • The Hill Medical Corporation; Pasadena, CA
  • Huron Valley Radiology; Ann Arbor, MI
  • Inland Imaging; Spokane, WA
  • Mecklenburg Radiology Associates; Charlotte, NC
  • Medical Center Radiology Group; Orlando, FL
  • Modesto Radiological Medical Group (MRMG); Modesto, CA
  • Mountain Medical Physician Specialists; Salt Lake City, UT
  • Naugatuck Valley Radiological Associates; Waterbury, CT
  • Northwest Radiology; Indianapolis, IN
  • Quantum Radiology; Atlanta, GA
  • Radiologic Medical Services; Iowa City, IA
  • Radiology Associates; Jeffersonville, IN
  • Radiology Associates of Macon; Macon, GA
  • Radiology Associates of North Texas; Dallas/Fort Worth, TX
  • Radiology Associates of Tallahassee; Tallahassee, FL
  • Rome Radiology Group; Rome, GA
  • Southeast Radiology, Ltd.; Glen Mills, PA
  • Tower Imaging Medical Group; Santa Monica, CA
  • United Imaging Consultants; Mission, KS
  • University Radiology; East Brunswick, NJ
  • X-Ray Consultants; South Bend, IN

Share article on social media or email:

Genomenon’s Mastermind Now Finds Therapies Associated with Genetic Drivers


Mastermind Genomic Search Engine by Genomenon

Mastermind users can now query the comprehensive database of genomic evidence for over 180,000 drugs, therapies, and other interventions.

Genomenon® announced today that the latest release of the Mastermind® Genomic Search Engine includes the ability to search by therapy. Mastermind users can now query the comprehensive database of genomic evidence for over 180,000 drugs, therapies, and other interventions.

This new offering furthers Genomenon’s ability to catalogue a complete dataset of all “Genomic Associations” supported by medical evidence. These associations help clinical labs more accurately and rapidly diagnose patients, and pharmaceutical companies make ground-breaking discoveries in the effective treatment cancer and other genetic diseases. Mastermind was launched in 2017 with the ability to uncover associations between diseases, genes, and variants, and has since added ACMG/AMP classification, phenotypes, and now therapies. Each new component of association data increases the power of Mastermind to allow users to find genetic evidence, test or generate hypotheses, and draw clinical conclusions with confidence.

Searching by therapy provides significant value for oncologists making decisions on third-line therapies, where approved drugs or clinical trials are no longer effective for a cancer patient. Finding a comprehensive list of all therapies in the medical research tied to a cancer patient’s genetic make-up is invaluable for treating these late-stage cancer patients.

The new search capability is also highly useful for clinicians making diagnostic and treatment decisions for patients with rare diseases. There are currently less than 800 FDA approved therapies for over 7,000 rare diseases, leaving many patients without an approved treatment option. In these cases, clinicians are required to scour the medical literature to find therapies associated with the patient’s genetic profile; a time-consuming and often fruitless task.

About Genomenon

Genomenon is a genomic health IT company that connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases.

The Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield, and assure repeatability in reporting genetic testing results.

Mastermind Genomic Landscapes inform pharmaceutical and bio-pharma companies on precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.

Genomenon was named 2020 Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan.

For more information, visit Genomenon.com.

Share article on social media or email:

Azoteq signs Distribution Agreement for Europe with their new distributor partner, Endrich


News Image

“We think Azoteq is a perfect addition to our portfolio for customized multiple sensor applications and its further alignment for mega trends like Artificial Intelligence, Smart home etc.,” said Dr. Christiane Endrich, CEO of Endrich.

Azoteq, a pioneer in sensor fusion, is pleased to announce the signing of a new European Distribution Agreement with Endrich.

Endrich has more than 40 years’ experience in providing quality components from reputable manufacturers and tailored solutions for applications from medium sized to big enterprises.

“Azoteq is excited to partner with an established specialist component distributor such as Endrich,” said Jean Viljoen, Azoteq’s VP of Marketing. “Endrich has an excellent reach into key European markets and will ensure even better service for our EU customer base.”

“We think Azoteq is a perfect addition to our portfolio for customized multiple sensor applications and its further alignment for mega trends like Artificial Intelligence, Smart home etc.,” said Dr. Christiane Endrich, CEO of Endrich.

Together with full technical support, Azoteq’s combination sensors, capacitive-touch and proximity ICs, touchpad ICs and modules for use in LED lighting, IoT, and wearable, mobile and security applications will now be more readily available to European clientele to ensure faster time to market.

For more information on and to order the full range of Azoteq products available through Endrich, visit: http://www.endrich.com.

About Endrich

Endrich is a design-oriented specialist distributor with a focus on passive components, optoelectronics, sensor technologies, electromechanics, acoustics and special semiconductor products. Thanks to tailor-made intensive technical support and sophisticated logistics Endrich stands for high-quality components and flexible customized solutions in Germany and Central Europe for more than 40 years.

About Azoteq (Pty) Ltd

Azoteq is a pioneer in sensor fusion. With more than a decade of capacitive-sensing experience, the sensor offering is now expanded to include multi-sensor technologies on single ICs. The first generation of ProxFusion® offers capacitive, Hall-effect, IR, PIR, inductive and ambient-light sensing. Azoteq has design and manufacturing centers in South Africa and China, and sales offices and distributors in South Africa, Asia, Europe and the USA.

IQ Switch®, ProxSense®, ProxFusion®, LightSense™, AirButton® and DYCAL™ are trademarks of Azoteq (Pty) Ltd.

Editorial Contact & Interviews:

Jean Viljoen

+27 21 863 0033

jean.viljoen@azoteq.com

http://www.azoteq.com

Share article on social media or email:

R3 Medical Training Announces Virtual Functional Medicine Course May 28-30th


Functional Medicine Certification Course

Virtual Functional Medicine Certification Course (888) 998-6343

We offer comprehensive functional medicine training in just THREE days for only $1995 with up to 20 CME Credits. Most organizations want providers to pay over five times that and spread the course out for a year. That makes no sense!

R3 Medical Training announced today it is accepting registrations for its live, virtual Functional Medicine Certification Course May 28-30, 2020. The three day course will be live streamed so that providers can take it from anywhere. Providers who take the course can receive up to 20 CME’s as well.

With Functional Medicine becoming more mainstream and extremely popular, providers nationwide have been asking R3 to add the course for years. Functional Medicine providers are able to evaluate the root cause of patient symptoms, rather than just masking problems with drugs.

According to R3 Medical Training CEO David Greene, MD, MBA, “We offer comprehensive functional medicine training in just THREE days for only $1995 with up to 20 CME Credits. Most organizations want providers to pay over five times that and spread the course out for a year. That makes no sense!”

Providers that sign up receive all the presentations and handouts to keep, along with a stellar BONUS Package that includes one on one live coaching along with a free book written by one of the instructors Dr. Tal Cohen.

The renowned group of instructors includes Dr. Liz Lipski, PhD, who has written several books on functional medicine and clinical nutrition along with being a Professor at Maryland University.

As mentioned, the three day course will be live streamed in HD and providers can take it from anywhere. This includes MD, DO, NP, ND, RN, DC, PT, acupunturists and more! Providers receive up to 20 CME Credits, which are Category 1.

To sign up for the course, simply visit https://functionalmedcertification.com or call (888) 998-6343.

Share article on social media or email: